Atlas Trials

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Clinical trial NCT01469598 · COMPLETED

Trial details

NCT number
NCT01469598
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic CarcinomaRecurrent Esophageal Squamous Cell Carcinoma
Start date
2011-08-01
Primary completion
2014-02-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.